DT TKA: RELIABILITY AND VALIDITY OF THE DT BALANCE TEST IN PATIENTS WITH TKA

Sponsor
Dokuz Eylul University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06108466
Collaborator
(none)
31
1
22.3
1.4

Study Details

Study Description

Brief Summary

The ability to perform a cognitive task while walking simultaneously is essential in real daily life. However, the psychometric properties of dual-task walking tests have not been well established in patients undergoing total knee arthroplasty (TKA). The aim of study assess the test-retest reliability and validity of dual conditions TUG, 3MBWT, 8FWT nad 4SST in patients with TKA.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    31 participants
    Observational Model:
    Case-Crossover
    Time Perspective:
    Cross-Sectional
    Official Title:
    RELIABILITY AND VALIDITY OF THE DUAL TASK BALANCE TEST IN PATIENTS WITH TOTAL KNEE ARTHROPLASTY
    Actual Study Start Date :
    Jan 14, 2022
    Anticipated Primary Completion Date :
    Nov 12, 2023
    Anticipated Study Completion Date :
    Nov 25, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Performance test [1 Hour]

      Timed Up and Go Test

    2. Performance Test [1 hour]

      3MWT

    3. Perfromance Test [1 hour]

      8 FWT

    4. Performance Test [1 hour]

      4SST

    Other Outcome Measures

    1. Patient Reported [1 hour]

      HSS Knee Score

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 90 Years
    Sexes Eligible for Study:
    All

    Inclusion Criteria: TKA -

    Exclusion Criteria: revision knee arthroplasty

    -

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dokuz Eylul University İzmir Turkey

    Sponsors and Collaborators

    • Dokuz Eylul University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Damla Ozcan, Msc. Pt, Dokuz Eylul University
    ClinicalTrials.gov Identifier:
    NCT06108466
    Other Study ID Numbers:
    • 6749-GOA
    First Posted:
    Oct 31, 2023
    Last Update Posted:
    Oct 31, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Damla Ozcan, Msc. Pt, Dokuz Eylul University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 31, 2023